about
The dopamine β-hydroxylase -1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis ProjectInvestigation of 15 of the top candidate genes for late-onset Alzheimer's diseaseAssociation and heterogeneity at the GAPDH locus in Alzheimer's diseaseGene expression levels as endophenotypes in genome-wide association studies of Alzheimer diseaseYKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer's disease and other tauopathies.Multiple insulin degrading enzyme variants alter in vitro reporter gene expressionReplication of CLU, CR1, and PICALM associations with alzheimer disease.Rare variants in calcium homeostasis modulator 1 (CALHM1) found in early onset Alzheimer's disease patients alter calcium homeostasis.Genetically-controlled Vesicle-Associated Membrane Protein 1 expression may contribute to Alzheimer's pathophysiology and susceptibility.SERPINA3 (aka alpha-1-antichymotrypsin).Confluence of α-synuclein, tau, and β-amyloid pathologies in dementia with Lewy bodies.Autosomal-dominant Alzheimer's disease mutations at the same codon of amyloid precursor protein differentially alter Aβ production.Acetylcholinesterase modulates presenilin-1 levels and γ-secretase activity.Weight loss in the healthy elderly might be a non-cognitive sign of preclinical Alzheimer's disease.Synaptic phosphorylated α-synuclein in dementia with Lewy bodies.Kidins220 Correlates with Tau in Alzheimer's Disease Brain and Cerebrospinal Fluid.c-Abl links APP-BACE1 interaction promoting APP amyloidogenic processing in Niemann-Pick type C disease.Measuring NLR Oligomerization IV: Using Förster Resonance Energy Transfer (FRET)-Fluorescence Lifetime Imaging Microscopy (FLIM) to Determine the Close Proximity of Inflammasome Components.Effect of REST on brain metabolism in the Alzheimer disease continuum.Presenilin-1 influences processing of the acetylcholinesterase membrane anchor PRiMA.Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene and the rate of cognitive decline in Alzheimer's disease.Investigating statistical epistasis in complex disorders.Interaction of insulin and PPAR-α genes in Alzheimer's disease: the Epistasis Project.Discovery by the Epistasis Project of an epistatic interaction between the GSTM3 gene and the HHEX/IDE/KIF11 locus in the risk of Alzheimer's disease.A SNP in the ACT gene associated with astrocytosis and rapid cognitive decline in AD.PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patientsPlasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional studyNanoscale structure of amyloid-β plaques in Alzheimer's diseaseChanges in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal FluidThe Epistasis Project: A Multi-Cohort Study of the Effects of BDNF, DBH, and SORT1 Epistasis on Alzheimer's Disease Risk
P50
Q21261508-27919143-7433-461A-AF04-182EB0AF0407Q24628049-E11BCE9F-7061-4895-916B-394B4592D025Q28294024-0A4E040E-DAC0-4285-94FC-C681D52C4B77Q33698166-517BF0DB-BA05-4B37-8FE7-EADCDDDB1568Q33784904-70D567A9-0897-4AC5-A2C7-1E591791DC15Q33952436-C99FC2D4-C49A-45F1-826D-E46C266A997FQ34058002-464ED3D3-CE2E-467A-997E-CA5285A17232Q34999034-C496CEB5-4BB2-40B9-86B1-72FE7BC238ADQ35589286-29CDFCB3-AA6E-4A32-BF51-2D027FD0624BQ36813610-130299E8-000D-4B50-906C-31725441B002Q38311234-49ED41D9-398F-4DF4-8543-6C353B77C9DEQ39080810-AB71DC93-A83D-490B-A648-CBC1B221D507Q46910159-B6F959CD-C31B-4F42-A2A6-88F809403E64Q47134219-2DB72285-F4EC-4DDD-9AB2-7D7AA7B33AD5Q47362946-D10617E2-201C-497E-A845-4AF9A8F39D2AQ48425790-84E8E059-E8D8-4C8C-9898-92F80C8D31BBQ48549247-0F3D778E-3BDF-4639-80B8-F4B30FFA9772Q50239209-8CC3C1A5-8D82-4D85-8E19-F59DB7FD4AD1Q50440328-192F5368-2218-469F-AA34-C04505BC6FDEQ50477395-60D94836-8541-473E-A905-01AC6FAB7A32Q53287830-0F96BC44-45DF-47C0-830A-5C936DC4093CQ53318198-76D78071-7BED-4E5D-9D97-E7FA2BD3A9C8Q53323657-C79E336E-5363-4CF1-B814-FAD84D265DDCQ53323657-D9D7F3D4-BBFF-4ACA-9808-2A8EFAB6DEE0Q53333515-ABD2F02F-0E23-4A17-90E3-583AFA4BFF5DQ53333515-BAE46FF7-A18B-4782-9F45-C9D3303EA1D3Q55043630-5E3AA658-9656-4575-87F6-DB42FC038A83Q55043630-C9FA06A7-F3BA-499A-81E1-45FF319C0C07Q57707212-45BA1932-443D-4E1C-AFBC-AE14121D4131Q59744545-9AC2B5B8-3AF2-422C-B1DA-16EF7FD64E27Q64018598-96D99043-EBDE-4EC9-956A-86F7E452837FQ64450771-CB9E7F47-0887-470C-AB84-7AD3D2B46024Q92603496-6965C105-CBC7-414C-8F59-4441B3B2EED9
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Olivia Belbin
@ast
Olivia Belbin
@en
Olivia Belbin
@es
Olivia Belbin
@nl
Olivia Belbin
@sl
type
label
Olivia Belbin
@ast
Olivia Belbin
@en
Olivia Belbin
@es
Olivia Belbin
@nl
Olivia Belbin
@sl
altLabel
Belbin O
@en
Olivia Belbin
@en
prefLabel
Olivia Belbin
@ast
Olivia Belbin
@en
Olivia Belbin
@es
Olivia Belbin
@nl
Olivia Belbin
@sl
P108
P106
P1153
16678370100
P21
P31
P496
0000-0002-6109-6371